Hims & Hers offers personalized telehealth services, with a stock price that reflects high-growth potential. See why we ...

Proton pump inhibitors are a class of medications used to treat conditions like GERD and ulcers. They work by blocking the ...

They keep costs low by prescribing generic versions of brand-name drugs, like Viagra and Cialis, that work just as well as ...

Hims & Hers Health, Inc. (NYSE:HIMS) investors will be delighted, with the company turning in some strong numbers with its latest results. It was overall a positive result, with revenues beating ...

The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic ...

Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025. "We have already confirmed a core supplier ...

At this time, I would like to welcome everyone to Hims & Hers Third Quarter 2024 Earnings ... Standard doses will work for many patients, however, given the diversity of obesity challenges across ...

Hims & Hers Health, Inc. HIMS delivered an earnings ... However, the gross margin contracted due to rising product costs. This does not bode well for the stock. Quest Diagnostics, carrying a ...

Hims & Hers Health, Inc. HIMS delivered an earnings per share (EPS) of 32 cents in third-quarter 2024 against the year-ago period’s loss of 4 cents per share. The metric was in line with the Zacks ...

Direct-to-consumer telehealth company Hims & Hers is defending its sale of compounded glucagon-like peptide agonists, or GLP-1s, even as shortages of the name brand weight loss medications are waning.

Telehealth platform Hims & Hers will begin offering a generic version of liraglutide, a GLP-1 weight loss drug, to its customers in 2025, Quartz reported Nov. 4. The move comes as patients ...

Hims & Hers will host a conference call to review the third quarter 2024 results on November 4, 2024, at 5:00 p.m. ET. The conference call can be accessed by dialing +1 (888) 510-2630 for U.S ...